G group (n = 89) | GR group (n = 89) | P value | |
---|---|---|---|
Age (y) | 46.1 ± 8.2 | 45.3 ± 8.0 | 0.512 |
Sex (male/female) | 45/44 | 36/53 | 0.176 |
BMI (kg/m2) | 24.92 ± 2.40 | 24.43 ± 1.77 | 0.123 |
Medical history | |||
Diabetes mellitus (n, yes/no) | 27/62 | 25/64 | 0.742 |
Hypertension (n, yes/no) | 40/49 | 48/41 | 0.230 |
Coronary heart disease (n, yes/no) | 11/78 | 8/81 | 0.466 |
ASA grade I/II/III | 32/50/7 | 36/43/10 | 0.524 |
NYHA grade I/II | 59/30 | 50/39 | 0.166 |
Total surgery time (min) | 517.58 ± 87.90 | 522.97 ± 95.73 | 0.697 |
Time to tracheal extubation (min) | 49.48 ± 5.07 | 37.45 ± 3.89 | < 0.001 |
Remifentanil (mg) | 4.21 ± 0.50 | 2.18 ± 0.20 | < 0.001 |
Rocuronium (mg) | 101.97 ± 10.85 | 84.26 ± 9.99 | < 0.001 |
Total fluid volume (ml) | 5491.36 ± 587.99 | 5543.36 ± 541.21 | 0.541 |
Urine volume (ml) | 1310.56 ± 161.35 | 1324.38 ± 153.75 | 0.559 |
Total volume of allogeneic erythrocyte infusion (ml) | 319.55 ± 235.82 | 329.21 ± 243.18 | 0.788 |
Total volume of plasma (ml) | 987.64 ± 114.14 | 973.71 ± 122.99 | 0.434 |